Patents Assigned to ELEMENT BIOSCIENCES, INC.
  • Patent number: 12618108
    Abstract: Fluorescence imaging systems designs, flow cell devices, and methods of are described herein that enable imaging of three or more axially displaced surfaces without using any optical compensators. The optical systems and flow cell devices herein provides higher throughput analysis for genomics and other imaging applications at a lower cost.
    Type: Grant
    Filed: January 10, 2025
    Date of Patent: May 5, 2026
    Assignee: Element Biosciences, Inc.
    Inventors: Steve Xiangling Chen, Omid Khandan, Chiting Chang, Derek Fuller, Jordan Neysmith, Michael Previte, Francisco Garcia
  • Patent number: 12612660
    Abstract: Fluorescence imaging system designs are described that provide larger fields-of-view, increased spatial resolution, improved modulation transfer and image quality, higher spatial sampling frequency, faster transitions between image capture when repositioning the fields-of-view, improved imaging system duty cycle and a more compact system, and thus enable higher throughput image acquisition and analysis for genomics and other imaging applications at a lower cost.
    Type: Grant
    Filed: January 19, 2024
    Date of Patent: April 28, 2026
    Assignee: Element Biosciences, Inc.
    Inventors: Arash Ghorbani, Russell Hudyma, John Bailey, Michael Previte
  • Patent number: 12606819
    Abstract: The present disclosure provides compositions comprising nucleic acid double-stranded splint adaptors, including kits, and methods that employ the double-stranded splint adaptors, e.g., PCR-free workflows. The double-stranded splint adaptors (200) can be used in a one-pot, multi-enzyme reaction to introduce one or more new adaptor sequences into a library molecule. The double-stranded splint adaptor (200) comprises a first splint strand (long splint strand (300)) and a second splint strand (short splint strand (400)), where the first and second splint strands are hybridized together to form the double-stranded splint adaptor (200) having a double-stranded region and two flanking single-stranded regions. The second splint strand (400) carries the new adaptor sequence(s) to be introduced, such as for example a universal binding sequence and/or an index sequence.
    Type: Grant
    Filed: July 5, 2023
    Date of Patent: April 21, 2026
    Assignee: Element Biosciences, Inc.
    Inventors: Junhua Zhao, Xiaodong Qi, Shawn Levy
  • Publication number: 20260094410
    Abstract: Methods and systems for image analysis are provided, and in particular for identifying a set of base-calling locations in a flow cell for DNA sequencing. These include capturing flow cell images after each sequencing step performed on the flow cell, and identifying candidate cluster centers in at least one of the flow cell images. Intensities are determined for each candidate cluster center in a set of flow cell images. Purities are determined for each candidate cluster center based on the intensities. Each candidate cluster center with a purity greater than the purity of the surrounding candidate cluster centers within a distance threshold is added to a template set of base-calling locations.
    Type: Application
    Filed: May 15, 2025
    Publication date: April 2, 2026
    Applicant: Element Biosciences, Inc.
    Inventors: Chunhong ZHOU, Semyon KRUGLYAK, Francisco GARCIA, Minghao GUO, Haosen WANG, Ryan KELLY
  • Patent number: 12540350
    Abstract: The present disclosure provides compositions, apparatuses and methods for capturing on a support nucleic acids from cellular samples, preparing library molecules on the support, amplifying the library molecules on the support to generate nucleic acid template molecules, and analyzing the immobilized nucleic acid template molecules including detecting and/or sequencing the immobilized nucleic acid template molecules. The immobilized nucleic acid template molecules correspond to the nucleic acids from the cellular samples. The immobilized nucleic acid template molecules are spatially located on the support at positions that correspond to the spatial location of the nucleic acids from the cellular sample.
    Type: Grant
    Filed: August 15, 2023
    Date of Patent: February 3, 2026
    Assignee: Element Biosciences, Inc.
    Inventors: Michael Previte, Shawn Levy
  • Patent number: 12516374
    Abstract: The present disclosure provides a compound of Formula (I), (II), or (III): an ionic derivative thereof, an isomer thereof, or a salt thereof. The present disclosure also provides conjugates of the compounds, and methods of using the compounds and the conjugates. The disclosure also provides the use of the compounds and conjugates in methods of sequencing nucleic acids.
    Type: Grant
    Filed: January 26, 2024
    Date of Patent: January 6, 2026
    Assignee: Element Biosciences, Inc.
    Inventors: Genhua Zheng, Njoo Audrey Wibawa, Xi Zhang, Zhimin Yang, Marcus James Jellen, Gene Shen
  • Patent number: 12492396
    Abstract: Provided herein are methods for generating circular nucleic acid molecules and circular nucleic acid libraries. The methods can be used to generate clonal populations of target nucleic acid molecules for downstream applications such as sequencing.
    Type: Grant
    Filed: May 13, 2021
    Date of Patent: December 9, 2025
    Assignee: Element Biosciences, Inc.
    Inventors: Matthew Kellinger, Sinan Arslan, Michael Previte, Junhua Zhao
  • Patent number: 12469162
    Abstract: Image data analysis, particularly identifying cluster locations for performing base-calling in a digital flow cell image during DNA sequencing, is described. Each nucleic acid template molecule immobilized on a support may include an insert sequence and a sample index sequence. The sample index sequence may include a k-mer sequence. A sequencing system may conduct k cycles of sequencing reactions of the k-mer sequence before conducting one or more cycles of the insert sequence sequencing reactions and generate a first plurality of flow cell images. Pixel intensities may be determined for pixels of the first plurality of flow cell images. A base calling template may be determined and include base calling locations based on the pixel intensities and respective color purities of the pixel intensities. The base calling template may register a second plurality of flow cell images of the support in one or more cycles subsequent to the k cycles.
    Type: Grant
    Filed: December 9, 2022
    Date of Patent: November 11, 2025
    Assignee: Element Biosciences, Inc.
    Inventors: Chunhong Zhou, Semyon Kruglyak, Francisco Garcia, Minghao Guo, Haosen Wang, Ryan Kelley
  • Patent number: 12421545
    Abstract: The present disclosure provides compositions and related methods, e.g., for preparing immobilized nucleic acid nanostructures using compaction oligonucleotides. In some embodiments, rolling circle amplification reaction can be conducted with compaction oligonucleotides on-support or in-solution to generate concatemer molecules having multiple copies of a polynucleotide unit arranged in tandem. Each polynucleotide unit comprises a sequence-of-interest and at least one universal adaptor sequence that binds one end of a compaction oligonucleotide. The 5? and 3? regions of the compaction oligonucleotide can hybridize to the concatemer to pull together distal portions of the concatemer causing compaction of the concatemer to form a nanostructure. Nanostructures having tighter size and shape compared to concatemers generated in the absence of the compaction oligonucleotides.
    Type: Grant
    Filed: August 15, 2023
    Date of Patent: September 23, 2025
    Assignee: Element Biosciences, Inc.
    Inventors: Sinan Arslan, Michael Kim, Ramreddy Tippana, Chunhong Zhou, William Light, Hua Yu, Junhua Zhao, Tsung-Li Liu
  • Patent number: 12391929
    Abstract: Compositions and methods comprising the use of polymerase-nucleotide conjugates for nucleic acid sequencing and analysis applications are described.
    Type: Grant
    Filed: June 8, 2020
    Date of Patent: August 19, 2025
    Assignee: Element Biosciences, Inc.
    Inventors: Matthew Kellinger, Michael Previte, Molly He, Tyler Lopez
  • Patent number: 12371743
    Abstract: The present disclosure provides compositions comprising nucleic acid double-stranded splint adaptors, including kits, and methods that employ the double-stranded splint adaptors. The double-stranded splint adaptors (200) can be used in a one-pot, multi-enzyme reaction to introduce one or more new adaptor sequences into a library molecule. The double-stranded splint adaptor (200) comprises a first splint strand (long splint strand (300)) and a second splint strand (short splint strand (400)), where the first and second splint strands are hybridized together to form the double-stranded splint adaptor (200) having a double-stranded region and two flanking single-stranded regions. The second splint strand (400) carries the new adaptor sequence(s) to be introduced, such as for example a universal binding sequence and/or an index sequence.
    Type: Grant
    Filed: April 20, 2022
    Date of Patent: July 29, 2025
    Assignee: Element Biosciences, Inc.
    Inventors: William Light, Samantha Snow, Junhua Zhao
  • Patent number: 12365892
    Abstract: The present disclosure provides compositions comprising nucleic acid double-stranded splint adaptors, including kits, and methods that employ the double-stranded splint adaptors. The double-stranded splint adaptors (200) can be used in a one-pot, multi-enzyme reaction to introduce one or more new adaptor sequences into a library molecule. The double-stranded splint adaptor (200) comprises a first splint strand (long splint strand (300)) and a second splint strand (short splint strand (400)), where the first and second splint strands are hybridized together to form the double-stranded splint adaptor (200) having a double-stranded region and two flanking single-stranded regions. The second splint strand (400) carries the new adaptor sequence(s) to be introduced, such as for example a universal binding sequence, an index sequence and/or a random sequence.
    Type: Grant
    Filed: September 12, 2023
    Date of Patent: July 22, 2025
    Assignee: Element Biosciences, Inc.
    Inventors: Junhua Zhao, Xiaodong Qi, Kelly Wiseman, Hua Yu, Matthew Kellinger
  • Patent number: 12359193
    Abstract: The present disclosure provides compositions comprising nucleic acid single-stranded splint strands, including kits, and methods that employ the single-stranded splint strands. The single-stranded splint strands can hybridize to portions of linear library molecules to form circularized library-splint complexes having a nick, where the nick can be ligated to form covalently closed circular molecules which can be subjected to downstream amplification and sequencing workflows.
    Type: Grant
    Filed: April 20, 2022
    Date of Patent: July 15, 2025
    Assignee: Element Biosciences, Inc.
    Inventors: William Light, Ryan Kelley, Junhua Zhao
  • Patent number: 12331356
    Abstract: Multivalent binding compositions including a particle-nucleotide conjugate having a plurality of copies of a nucleotide attached to the particle are described. The multivalent binding compositions allow one to localize detectable signals to active regions of biochemical interaction, e.g., sites of protein-protein interaction, protein-nucleic acid interaction, nucleic acid hybridization, or enzymatic reaction, and can be used to identify sites of base incorporation in elongating nucleic acid chains during polymerase reactions and to provide improved base discrimination for sequencing and array based applications.
    Type: Grant
    Filed: January 22, 2021
    Date of Patent: June 17, 2025
    Assignee: ELEMENT BIOSCIENCES, INC.
    Inventors: Sinan Arslan, Chunhong Zhou, Molly Min He, Matthew Kellinger, Hui Zhen Mah, Michael Previte, Lei Sun
  • Patent number: 12313627
    Abstract: Multivalent binding compositions including a particle-nucleotide conjugate having a plurality of copies of a nucleotide attached to the particle are described. The multivalent binding compositions allow one to localize detectable signals to active regions of biochemical interaction, e.g., sites of protein-protein interaction, protein-nucleic acid interaction, nucleic acid hybridization, or enzymatic reaction, and can be used to identify sites of base incorporation in elongating nucleic acid chains during polymerase reactions and to provide improved base discrimination for sequencing and array based applications.
    Type: Grant
    Filed: February 2, 2024
    Date of Patent: May 27, 2025
    Assignee: ELEMENT BIOSCIENCES, INC.
    Inventors: Sinan Arslan, Molly He, Michael Previte
  • Patent number: 12270056
    Abstract: Provided herein are engineered variants of archaeal, prokaryotic, and eukaryotic polymerases that exhibit enhanced thermostability, enhanced incorporation of 3? modified nucleotides, and improved uracil-tolerance, in polymerase-catalyzed nucleotide extension reactions relative to wild type polymerase enzymes. Also provided are uses of the engineered polymerases for forming complexed polymerases, forming binding complexes and forming ternary complexes, and uses for conducting nucleic acid sequencing reactions.
    Type: Grant
    Filed: March 25, 2022
    Date of Patent: April 8, 2025
    Assignee: ELEMENT BIOSCIENCES, INC.
    Inventors: Mark Ambroso, Tyler Lopez, Michael Klein, Virginia Saade, Matthew Kellinger
  • Patent number: 12241891
    Abstract: Multivalent binding compositions including a particle-nucleotide conjugate having a plurality of copies of a nucleotide attached to the particle are described. The multivalent binding compositions allow one to localize detectable signals to active regions of biochemical interaction, e.g., sites of protein-protein interaction, protein-nucleic acid interaction, nucleic acid hybridization, or enzymatic reaction, and can be used to identify sites of base incorporation in elongating nucleic acid chains during polymerase reactions and to provide improved base discrimination for sequencing and array based applications.
    Type: Grant
    Filed: February 18, 2022
    Date of Patent: March 4, 2025
    Assignee: ELEMENT BIOSCIENCES, INC.
    Inventors: Michael Previte, Molly He, Junhua Zhao, Hui Zhen Mah, Chunhong Zhou, Sinan Arslan, Matthew Kellinger, Lorenzo Berti, Steve Xiangling Chen
  • Patent number: 12163163
    Abstract: Provided herein are engineered variants of archaeal polymerases that exhibit exonuclease-minus activity, enhanced thermostability, enhanced incorporation of 3? modified nucleotides, improved uracil-tolerance and/or reduce sequence-specific errors in polymerase-catalyzed nucleotide binding and extension reactions relative to wild type polymerase enzymes. Also provided are uses of the engineered polymerases for forming complexed polymerases and forming binding complexes, and uses for conducting nucleic acid sequencing reactions.
    Type: Grant
    Filed: January 27, 2023
    Date of Patent: December 10, 2024
    Assignee: ELEMENT BIOSCIENCES, INC.
    Inventors: Jendrik Boothby-Hentschel, Tyler Lopez, Michael Klein, Virginia Saade, Matthew Kellinger, Mark Ambroso
  • Patent number: 12146190
    Abstract: Fluorescence imaging system designs are described that provide larger fields-of-view, increased spatial resolution, improved modulation transfer and image quality, higher spatial sampling frequency, faster transitions between image capture when repositioning the fields-of-view, improved imaging system duty cycle and a more compact system, and thus enable higher throughput image acquisition and analysis for genomics and other imaging applications at a lower cost.
    Type: Grant
    Filed: January 19, 2024
    Date of Patent: November 19, 2024
    Assignee: ELEMENT BIOSCIENCES, INC.
    Inventors: Arash Ghorbani, Russell Hudyma, John Bailey, Michael Previte
  • Patent number: 12139727
    Abstract: Provided herein are engineered variants of archaeal, prokaryotic, and eukaryotic polymerases that exhibit enhanced thermostability, enhanced incorporation of 3? modified nucleotides, and improved uracil-tolerance, in polymerase-catalyzed nucleotide extension reactions relative to wild type polymerase enzymes. Also provided are uses of the engineered polymerases for forming complexed polymerases, forming binding complexes and forming ternary complexes, and uses for conducting nucleic acid sequencing reactions.
    Type: Grant
    Filed: March 25, 2022
    Date of Patent: November 12, 2024
    Assignee: ELEMENT BIOSCIENCES, INC.
    Inventors: Mark Ambroso, Tyler Lopez, Michael Klein, Virginia Saade, Matthew Kellinger